Does evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?: Reply.

Wiegman A, Raal FJ, Bhatia AK

Open source

DOI
10.1093/eurjpc/zwaf005
Published
2026 Jul 14
Container
European journal of preventive cardiology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/eurjpc/zwaf005,
  title = {Does evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?: Reply.},
  author = {Wiegman A and Raal FJ and Bhatia AK},
  year = {2026},
  journal = {European journal of preventive cardiology},
  doi = {10.1093/eurjpc/zwaf005},
  url = {https://doi.org/10.1093/eurjpc/zwaf005}
}

RIS

TY  - JOUR
TI  - Does evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?: Reply.
AU  - Wiegman A
AU  - Raal FJ
AU  - Bhatia AK
PY  - 2026
JO  - European journal of preventive cardiology
DO  - 10.1093/eurjpc/zwaf005
UR  - https://doi.org/10.1093/eurjpc/zwaf005
ER  - 

APA

A, W., FJ, R., & AK, B. (2026). Does evolocumab treatment reduce carotid intima-media thickness in paediatric patients with heterozygous familial hypercholesterolaemia?: Reply.. European journal of preventive cardiology. https://doi.org/10.1093/eurjpc/zwaf005

Source records